. OVERVIEW Rafael Holdings, Inc. (Rafael Holdings, Rafael, we or the Company) is a biotechnology company that develops pharmaceuticals and holds interests in clinical and early-stage companies that develop pharmaceuticals and medical devices. Our lead candidate is Trappsol Cyclo, which is being evaluated in clinical trials for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal and progressive genetic disorder. We also hold: (i) a majority equity interest in LipoMedix P...
Q2 FY2026 — expected 2026-08-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-29 | 2025-07-31 | 0001213900-25-103549 | EDGAR | 120K words |
| 2024-11-07 | 2024-07-31 | 0001213900-24-095111 | EDGAR | — |
| 2023-10-30 | 2023-07-31 | 0001213900-23-081589 | EDGAR | — |
| 2022-10-31 | 2022-07-31 | 0001213900-22-067711 | EDGAR | — |
| 2021-10-18 | 2021-07-31 | 0001213900-21-053306 | EDGAR | — |
| 2020-10-29 | 2020-07-31 | 0001213900-20-033974 | EDGAR | — |
| 2019-10-04 | 2019-07-31 | 0001213900-19-019707 | EDGAR | — |
| 2018-10-15 | 2018-07-31 | 0001213900-18-013948 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2026-01-31 | 0001213900-26-028348 | EDGAR | 38K words |
| 2025-12-12 | 2025-10-31 | 0001213900-25-120897 | EDGAR | — |
| 2025-06-11 | 2025-04-30 | 0001213900-25-053273 | EDGAR | — |
| 2025-03-14 | 2025-01-31 | 0001213900-25-023799 | EDGAR | — |
| 2024-12-11 | 2024-10-31 | 0001213900-24-107637 | EDGAR | — |
| 2024-06-14 | 2024-04-30 | 0001213900-24-052918 | EDGAR | — |
| 2024-03-14 | 2024-01-31 | 0001213900-24-022343 | EDGAR | — |
| 2023-12-14 | 2023-10-31 | 0001213900-23-095748 | EDGAR | — |
| 2023-06-13 | 2023-04-30 | 0001213900-23-048592 | EDGAR | — |
| 2023-03-14 | 2023-01-31 | 0001213900-23-019981 | EDGAR | — |
| 2022-12-13 | 2022-10-31 | 0001213900-22-079292 | EDGAR | — |
| 2022-06-14 | 2022-04-30 | 0001213900-22-032831 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-16 | 0001213900-26-028311 | EDGAR | 3K words |
| 2026-01-12 | 0001213900-26-003411 | EDGAR | — |
| 2025-12-11 | 0001213900-25-120691 | EDGAR | — |
| 2025-12-02 | 0001213900-25-116951 | EDGAR | — |
| 2025-10-29 | 0001213900-25-103509 | EDGAR | — |
| 2025-10-28 | 0001213900-25-103087 | EDGAR | — |
| 2025-10-10 | 0001213900-25-097965 | EDGAR | — |
| 2025-08-07 | 0001213900-25-073104 | EDGAR | — |
| 2025-07-18 | 0001213900-25-065353 | EDGAR | — |
| 2025-06-18 | 0001213900-25-055402 | EDGAR | — |
167 total filings indexed. 137 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001713863 |
| Ticker | RFL |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.rafaelholdings.com |
| Listed | 2018-03-06 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report